杭州珺泽生物医药有限公司是一家以科技创新为引擎的制药企业,目前主营业务聚焦于抗肿瘤及自身免疫性疾病领域的大分子偶联药物及纳米药物精准递送技术开发。核心产品覆盖注射剂、口服药物等方向。目前公司首发核心项目已正式向国家药品监督管理局提交IND,并顺利进入技术评审阶段。在研产品管线未来市场潜力巨大,且公司也在积极规划海外业务,为后续全球化发展奠定基础。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows